BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/09/2004

National Cancer Institute Seeks Collaborators for Antiangiogenic Drug Development

The National Cancer Institute is seeking partners to develop novel antiangiogenic agents targeting adrenomedullin gene products for potential clinical testing and licensing opportunities.

Source: Federal Register — Health and Human ServicesOpen original release →